Pharma Mar SA (PHMMF)
87.58
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Pharma Mar Shareholders Equity (Quarterly) : 286.71M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 286.71M |
| March 31, 2026 | 287.67M |
| December 31, 2025 | 295.77M |
| September 30, 2025 | 232.07M |
| June 30, 2025 | 236.57M |
| March 31, 2025 | 213.31M |
| December 31, 2024 | 215.76M |
| September 30, 2024 | 203.31M |
| June 30, 2024 | 194.40M |
| March 31, 2024 | 208.09M |
| December 31, 2023 | 213.68M |
| September 30, 2023 | 218.31M |
| June 30, 2023 | 229.44M |
| March 31, 2023 | 235.68M |
| December 31, 2022 | 237.95M |
| September 30, 2022 | |
| June 30, 2022 | 216.34M |
| March 31, 2022 | 224.53M |
| December 31, 2021 | 202.33M |
| September 30, 2021 | 165.97M |
| June 30, 2021 | 159.92M |
| March 31, 2021 | 149.88M |
| December 31, 2020 | 125.69M |
| September 30, 2020 | 115.10M |
| June 30, 2020 | 120.66M |
| Date | Value |
|---|---|
| March 31, 2020 | 89.21M |
| December 31, 2019 | 12.77M |
| September 30, 2019 | -5.774M |
| June 30, 2019 | 0.1469M |
| March 31, 2019 | 12.80M |
| December 31, 2018 | 24.43M |
| September 30, 2018 | 37.32M |
| June 30, 2018 | 35.05M |
| March 31, 2018 | 31.40M |
| December 31, 2017 | 32.26M |
| September 30, 2017 | 46.23M |
| June 30, 2017 | 53.68M |
| March 31, 2017 | 53.44M |
| December 31, 2016 | 55.22M |
| September 30, 2016 | 67.39M |
| June 30, 2016 | 69.43M |
| March 31, 2016 | 78.99M |
| December 31, 2015 | 83.51M |
| September 30, 2015 | 90.13M |
| June 30, 2015 | 85.07M |
| March 31, 2015 | 75.12M |
| December 31, 2014 | 77.30M |
| September 30, 2014 | 87.92M |
| June 30, 2014 | 94.38M |
| March 31, 2014 | 96.03M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oryzon Genomics SA | 119.16M |
| Grifols SA | 6.341B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alkermes Plc | 1.809B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 450.00M |
| Total Liabilities (Quarterly) | 162.32M |
| Debt to Equity Ratio | 0.1828 |
| Current Ratio | 2.855 |
| Net Debt Paydown Yield | 0.05% |